SUMMARY

Oncophenomics is a company specializing in the development of liquid biopsy and genomic profiling tests for cancer diagnosis and treatment. The company offers two primary products: Oncotrack: A liquid biopsy test that can detect cancer recurrence, relapse, or metastasis significantly earlier than traditional imaging modalities. This test also monitors therapy response and identifies resistance mechanisms. Oncopredict: A genomic profiling test designed to predict the effectiveness of targeted therapies or immunotherapies based on the molecular profile of the tumor. It also helps identify potential biomarkers and drug targets. The tests developed by Oncophenomics have several advantages over conventional methods. They are non-invasive, requiring only a blood sample or a minimal tissue sample, which makes them painless and safe. Additionally, they are affordable, fast, accessible, and utilize low-cost, high-throughput technologies suitable for any laboratory. The tests are sensitive and specific, capable of detecting minute amounts of circulating tumor DNA (ctDNA) or tumor mutations and distinguishing them from normal DNA or mutations. They offer a comprehensive and representative snapshot of tumor heterogeneity and dynamics. Oncophenomics has made a significant impact on the cancer community in both India and abroad, serving B2B customers like hospitals, clinics, research institutes, and B2C clients, including oncologists, pathologists, and patients. The company has been recognized for its innovative and impactful model, receiving grants and incubation support from various organizations. Oncophenomics aims to scale up its operations and enhance its technology. The company is exploring advanced technologies like blockchain, IoT, and AI to improve its platform's security, accuracy, and efficiency. Oncophenomics also seeks partnerships and collaborations to create a more inclusive and sustainable healthcare ecosystem.

PRODUCTS

Gene Synthesis: Custom high-fidelity gene fragments, DNA Cloning: Custom DNA fragments, up to 7,000 bp, cloned into any vector

SERVICES

The services offered by Oncophenomics include personalized medicine for cancer diagnostics and clinical outcomes using cloud computing, genomics, liquid biopsy, machine learning/deep learning, next-generation sequencing, and software

FOUNDER DETAILS

ABOUT

Oncophenomics is a personalized medicine startup pioneering the latest cutting edge technologies to help improve cancer diagnostics and clinical outcomes.

COMPANY TYPE

SERVICE VERTICALS

• Medical Diagnostics

TECHNOLOGY

• Cloud
• Genomics
• Liquid Biopsy
• Machine Learning / Deep Learning
• Software
• Next Generation Sequencing

THERAPEUTIC AREAS

• Oncology

VALUE OFFERING

• Research
• Diagnosis

LOCATION

4th Floor CRTDH, CCMB Annex II, Medical Biotechnology Building, Habsiguda, Hyderabad, TS 500039

TARGET USERS

• Corporate
• HCP
• Patients

INCORPORATION DATE

May 2, 2016

STATE/CITY

Telangana, Hyderabad